GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset Read More » May 31, 2023
Curium Receives Positive CHMP Opinion of PYLCLARI® for Primary Staging of Patients With High-Risk PCa Prior to Initial Curative Therapy and to Localize Recurrence of PCa in Patients With a Suspected Recurrence Based on Increasing Serum Prostate-Specific Antigen (PSA) Levels After Primary Treatment With Curative Intent Read More » May 26, 2023
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023 Read More » May 26, 2023
Novavax’s Nuvaxovid ™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EU Read More » May 26, 2023